Select Publications
Journal articles
2013, 'Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region', PLoS ONE, 8, pp. e64902, http://dx.doi.org/10.1371/journal.pone.0064902
,2013, 'Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Population movement can sustain STI prevalence in remote Australian indigenous communities', BMC Infectious Diseases, 13, pp. 188, http://dx.doi.org/10.1186/1471-2334-13-188
,2013, 'Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection', Vaccine, 31, pp. 1931 - 1936, http://dx.doi.org/10.1016/j.vaccine.2013.02.018
,2013, 'On the use of fractional polynomial models to assess preventive aspect of variables: An example in prevention of mortality following HIV infection', International Journal of Preventive Medicine, 4, pp. 414 - 419
,2013, 'Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use', Clinical Infectious Diseases, 56, pp. 777 - 786, http://dx.doi.org/10.1093/cid/cis1030
,2013, 'Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events', AIDS, 27, pp. 407 - 415, http://dx.doi.org/10.1097/QAD.0b013e32835b2ef1
,2013, 'A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa - The International epidemiologic Databases to Evaluate AIDS (IeDEA)', Journal of the International AIDS Society, 16, http://dx.doi.org/10.7448/IAS.16.1.17998
,2013, 'Intensity of human prion disease surveillance predicts observed disease incidence', Journal of Neurology, Neurosurgery and Psychiatry, 84, pp. 1372 - 1377, http://dx.doi.org/10.1136/jnnp-2012-304820
,2013, 'Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience', HIV Medicine, 14, pp. 208 - 216, http://dx.doi.org/10.1111/j.1468-1293.2012.01053.x
,2013, 'Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: The D: A: D study', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 63, pp. 456 - 463, http://dx.doi.org/10.1097/QAI.0b013e318291cd29
,2013, 'Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01-AE and subtype B', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 62, pp. 293 - 300, http://dx.doi.org/10.1097/QAI.0b013e31827a2e8f
,2013, 'High rates of late HIV diagnosis among people who inject drugs compared to men who have sex with men and heterosexual men and women in Australia', AIDS and Behavior, 17, pp. 235 - 241, http://dx.doi.org/10.1007/s10461-011-0117-6
,2013, 'The association of HPV-16 seropositivity and natural immunity to reinfection: Insights from compartmental models', BMC Infectious Diseases, 13, pp. 83, http://dx.doi.org/10.1186/1471-2334-13-83
,2012, 'THE AUSTRALIAN CHLAMYDIA CONTROL EFFECTIVENESS PILOT (ACCEPT): FIRST RESULTS FROM A RANDOMISED TRIAL OF ANNUAL CHLAMYDIA SCREENING IN GENERAL PRACTICE', SEXUALLY TRANSMITTED INFECTIONS, 88, pp. A3 - A4, http://dx.doi.org/10.1136/sextrans-2012-050601a.8
,2012, 'Objective measurements of surveillance intensity predict disease incidence and guide ascertainment adequacy in sporadic Creutzfeldt-Jakob disease', PRION, 6, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304234300138&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion – the Health in Men (HIM) Biomarker sub-study', Antiviral Therapy, 18, pp. 355 - 359, http://dx.doi.org/10.3851/IMP2434
,2012, 'Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific', International Journal of Epidemiology, 41, pp. 43 - 54, http://dx.doi.org/10.1093/ije/dyq192
,2012, 'Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: Results from a modified back-projection model', AIDS and Behavior, 16, pp. 360 - 367, http://dx.doi.org/10.1007/s10461-011-9969-z
,2012, 'Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial', Lancet Infectious Diseases, 12, pp. 933 - 941, http://dx.doi.org/10.1016/S1473-3099(12)70242-6
,2012, 'Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy', Sexually Transmitted Infections, 88, pp. i33 - i43, http://dx.doi.org/10.1136/sextrans-2012-050658
,2012, 'Estimating the cost-effectiveness of needle-syringe programs in Australia.', AIDS, 26, pp. 2201 - 2210, http://dx.doi.org/10.1097/QAD.0b013e3283578b5d
,2012, 'Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke.', , 205, pp. 535 - 539
,2012, 'Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: Results from the Treat Asia HIV observational database', Journal of the International AIDS Society, 15, pp. Article number1, http://dx.doi.org/10.1186/1758-2652-15-1
,2012, 'Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: A placebo-controlled crossover trial.', Heart, 98, pp. 282 - 290, http://dx.doi.org/10.1136/heartjnl-2011-300751
,2012, 'Hepatitis C treatment outcomes in Australian clinics', Medical Journal of Australia, 196, pp. 633 - 637, http://dx.doi.org/10.5694/mja12.10014
,2012, 'Human papillomavirus and head and neck cancers: emerging trends and improving survival', Australian and New Zealand Journal of Public Health, 36, pp. 195 - 196, http://dx.doi.org/10.1111/j.1753-6405.2012.00860.x
,2012, 'Increased mortality among Indigenous persons during and after release from prison in New South Wales', Australian and New Zealand Journal of Public Health, 36, pp. 274 - 280, http://dx.doi.org/10.1111/j.1753-6405.2012.00844.x
,2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839
,2012, 'Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD', AIDS Research and Treatment, 2012, pp. Article ID 375217, http://dx.doi.org/10.1155/2012/375217
,2012, 'Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease', Nephrology Dialysis Transplantation, 27, pp. 70 - 75, http://dx.doi.org/10.1093/ndt/gfr575
,2012, 'Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time.', Transplant Infectious Disease, 14, pp. 278 - 287, http://dx.doi.org/10.1111/j.1399-3062.2012.00734.x
,2012, 'Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study', Journal of the International AIDS Society, 15, pp. Article number17426, http://dx.doi.org/10.7448/IAS.15.2.17426
,2012, 'Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals', AIDS, 26, pp. 1707 - 1717, http://dx.doi.org/10.1097/QAD.0b013e328355d659
,2012, 'Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?', Cancer Epidemiology Biomarkers and Prevention, 21, pp. 337 - 346, http://dx.doi.org/10.1158/1055-9965.EPI-11-0786
,2012, 'Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and Central and South America', Journal of the International AIDS Society, 15, pp. Article number 5, http://dx.doi.org/10.1186/1758-2652-15-5
,2012, 'Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort', Hepatology Research, 42, pp. 1175 - 1186, http://dx.doi.org/10.1111/j.1872-034X.2012.01037.x
,2011, 'HIV and aging: An overview of an emerging issue', Sexual Health, 8, pp. 449 - 451, http://dx.doi.org/10.1071/SH11110
,2011, 'AUSTRALIAN CHLAMYDIA CONTROL EFFECTIVENESS PILOT: PRELIMINARY RESULTS FROM A TRIAL OF CHLAMYDIA TESTING IN GENERAL PRACTICE', SEXUALLY TRANSMITTED INFECTIONS, 87, pp. A202 - A202, http://dx.doi.org/10.1136/sextrans-2011-050108.240
,2011, 'Editorial introductions', Current Opinion in HIV and AIDS, 6, http://dx.doi.org/10.1097/COH.0b013e328348cb1f
,2011, 'Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study (AIDS (2010) 24, (1537-1548))', AIDS, 25, pp. 883, http://dx.doi.org/10.1097/QAD.0b013e328343f97f
,2011, 'Trends in anal cancer in Australia, 1982-2005.', Vaccine, 29, pp. 2322 - 2327
,2011, 'A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 14, http://dx.doi.org/10.1186/1758-2652-14-7
,2011, 'CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts', Journal of acquired immune deficiency syndromes (1999), 58, pp. 72 - 79, http://dx.doi.org/10.1097/QAI.0b013e318225ba62
,2011, 'Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the australian HIV observational database', PLoS One, 6, pp. e20713, http://dx.doi.org/10.1371/journal.pone.0020713
,2011, 'Counting the cost: estimating the number of deaths among recently released prisoners in Australia', Australian Journal of Medical Science, 195, pp. 64 - 68
,2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x
,2011, 'Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings', AIDS, 25, pp. 1143 - 1151, http://dx.doi.org/10.1097/QAD.0b013e3283466fab
,2011, 'Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers', British Journal of Cancer, 104, pp. 886 - 891, http://dx.doi.org/10.1038/sj.bjc.6606091
,2011, 'HIV in hiding: Methods and data requirements for the estimation of the number of people living with undiagnosed HIV', AIDS, 25, pp. 1017 - 1023
,